EcoR1 Capital as of June 30, 2024
Portfolio Holdings for EcoR1 Capital
EcoR1 Capital holds 55 positions in its portfolio as reported in the June 2024 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Apellis Pharmaceuticals (APLS) | 13.6 | $445M | 12M | 38.36 | |
| Prothena Corp SHS (PRTA) | 7.3 | $239M | 12M | 20.64 | |
| Sarepta Therapeutics (SRPT) | 6.8 | $222M | 1.4M | 158.00 | |
| Anaptysbio Inc Common (ANAB) | 5.8 | $189M | 7.5M | 25.06 | |
| Crinetics Pharmaceuticals In (CRNX) | 5.7 | $186M | 4.2M | 44.79 | |
| Arvinas Ord (ARVN) | 5.5 | $179M | 6.7M | 26.62 | |
| Morphic Hldg (MORF) | 5.2 | $170M | 5.0M | 34.07 | |
| Galapagos Nv Spon Adr (GLPG) | 4.4 | $143M | 5.8M | 24.78 | |
| Kura Oncology (KURA) | 3.7 | $120M | 5.8M | 20.59 | |
| Tango Therapeutics (TNGX) | 3.5 | $114M | 13M | 8.58 | |
| Zymeworks Del (ZYME) | 3.5 | $114M | 13M | 8.51 | |
| Jazz Pharmaceuticals Shs Usd (JAZZ) | 3.3 | $108M | 1.0M | 106.73 | |
| Xencor (XNCR) | 3.1 | $101M | 5.3M | 18.93 | |
| Crispr Therapeutics Namen Akt (CRSP) | 2.3 | $75M | 1.4M | 54.01 | |
| Janux Therapeutics (JANX) | 1.9 | $62M | 1.5M | 41.89 | |
| Nuvation Bio Com Cl A (NUVB) | 1.7 | $56M | 19M | 2.92 | |
| Centessa Pharmaceuticals Sponsored Ads (CNTA) | 1.6 | $52M | 5.7M | 9.03 | |
| Iteos Therapeutics (ITOS) | 1.5 | $48M | 3.2M | 14.84 | |
| Immunome (IMNM) | 1.4 | $47M | 3.9M | 12.10 | |
| Neurogene (NGNE) | 1.4 | $46M | 1.3M | 36.39 | |
| Third Harmonic Bio (THRD) | 1.3 | $41M | 3.2M | 13.00 | |
| Mersana Therapeutics (MRSN) | 1.2 | $39M | 19M | 2.01 | |
| Voyager Therapeutics (VYGR) | 0.9 | $31M | 3.9M | 7.91 | |
| Avidity Biosciences Ord (RNA) | 0.9 | $31M | 758k | 40.85 | |
| Tscan Therapeutics (TCRX) | 0.9 | $29M | 5.0M | 5.85 | |
| Adaptimmune Therapeutics Sponds Adr (ADAP) | 0.8 | $27M | 27M | 0.97 | |
| Oric Pharmaceuticals (ORIC) | 0.7 | $24M | 3.4M | 7.07 | |
| Cargo Therapeutics (CRGX) | 0.7 | $24M | 1.5M | 16.42 | |
| Celldex Therapeutics Com New (CLDX) | 0.7 | $24M | 650k | 37.01 | |
| Vaxcyte (PCVX) | 0.7 | $23M | 300k | 75.51 | |
| Edgewise Therapeutics (EWTX) | 0.7 | $23M | 1.3M | 18.01 | |
| ACADIA Pharmaceuticals (ACAD) | 0.7 | $22M | 1.3M | 16.25 | |
| Lenz Therapeutics (LENZ) | 0.6 | $21M | 1.2M | 17.29 | |
| Madrigal Pharmaceuticals (MDGL) | 0.6 | $21M | 75k | 280.16 | |
| Neumora Therapeutics (NMRA) | 0.6 | $20M | 2.1M | 9.83 | |
| Bicycle Therapeutics Sponsored Ads (BCYC) | 0.6 | $18M | 910k | 20.24 | |
| Atea Pharmaceuticals (AVIR) | 0.6 | $18M | 5.4M | 3.31 | |
| Pharvaris N V (PHVS) | 0.5 | $17M | 900k | 18.80 | |
| Dyne Therapeutics (DYN) | 0.5 | $15M | 427k | 35.29 | |
| Tectonic Therapeutic Com Added (TECX) | 0.4 | $14M | 849k | 16.47 | |
| Rocket Pharmaceuticals (RCKT) | 0.3 | $11M | 508k | 21.53 | |
| Keros Therapeutics (KROS) | 0.3 | $8.6M | 188k | 45.70 | |
| Allovir (ALVR) | 0.2 | $8.2M | 11M | 0.72 | |
| Replimune Group (REPL) | 0.2 | $7.7M | 850k | 9.00 | |
| Verve Therapeutics (VERV) | 0.2 | $6.1M | 1.3M | 4.88 | |
| Generation Bio (GBIO) | 0.2 | $5.8M | 2.0M | 2.82 | |
| Prime Medicine (PRME) | 0.1 | $3.6M | 700k | 5.14 | |
| Atara Biotherapeutics Com New Added (ATRA) | 0.1 | $3.5M | 407k | 8.50 | |
| Proqr Thrapeutics N V Shs Euro (PRQR) | 0.1 | $3.4M | 2.0M | 1.66 | |
| Hookipa Pharma Inc equity | 0.1 | $3.4M | 5.7M | 0.59 | |
| Kyverna Therapeutics (KYTX) | 0.1 | $3.4M | 450k | 7.50 | |
| Nuvation Bio *w Exp 07/07/202 (NUVB.WS) | 0.1 | $2.8M | 963k | 2.92 | |
| Aligos Therapeutics | 0.1 | $2.2M | 6.4M | 0.35 | |
| Surrozen *w Exp 08/01/203 (SRZNW) | 0.0 | $730k | 67k | 10.95 | |
| Caremax *w Exp 06/08/202 | 0.0 | $279k | 100k | 2.79 |
